Edwin C Pratt
theprattlab.bsky.social
Edwin C Pratt
@theprattlab.bsky.social
Assistant Professor of Radiology @Stony Brook Cancer Center. Developer of new theranostics for the detection and elimination of pancreatic and other rare cancers.
The Pratt Lab is looking for a postdoctoral associate to build new theranostics! Apply today and please spread the word if you can! Deadline is Nov 13th so act fast!

stonybrooku.taleo.net/careersectio...
Postdoctoral Associate
Click the link provided to see the complete job description.
stonybrooku.taleo.net
October 31, 2025 at 2:56 PM
Excited to report the Pratt Lab at Stony Brook in their Cancer Center is open! Keep an eye out for hiring notices! Many thanks to @lewislabmskcc.bsky.social for the mentorship during my years at MSKCC. The lab will be focused on chemogenic combinations with theranostics to treat pancreatic cancer.
October 24, 2025 at 6:41 PM
Reposted by Edwin C Pratt
Happy proofs day to those who celebrate…

Details forthcoming!

#radiopharmaceuticals #theranostics #hcc
July 22, 2025 at 12:46 AM
Excited to share hot off the press our paper outlining a new mesothelin antibody for PET imaging. Many thanks to members of the @lewislabmskcc.bsky.social and Eli Lilly and Co. for making this paper happen!
authors.elsevier.com/c/1lTO73SWXP...
authors.elsevier.com
July 21, 2025 at 8:47 PM
Fantastic talk by fellow @paulklauser.bsky.social at iSRS on covalent binding PET tracers! Brilliant work!
May 12, 2025 at 5:13 AM
Looking to compare brightness between radionuclides? look no further! Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System. A collection over the years including over 23 radionuclides! @grimmrad.bsky.social and @lewislabmskcc.bsky.social
jnm.snmjournals.org/content/earl...
Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
Cerenkov (or Cherenkov) luminescence occurs when charged particles exceed the phase velocity of a given medium. Cerenkov as a modality has gained interest for visualization of numerous radionuclides. ...
jnm.snmjournals.org
April 4, 2025 at 8:38 PM
Out now at Clin Cancer Research we characterized a new Trop-2 antibody for rapid tumor detection in pancreatic, ovarian, and prostate cancers. We also leveraged pretargeting for rapid, high-capacity imaging. Huge thanks to our collaborators for the amazing work!

aacrjournals.org/clincancerre...
Pretargeted Trop-2 immunoPET for rapid, selective detection of pancreatic tumors
Abstract. Purpose: Recent clinical advances with the approval of antibody-drug conjugates targeting Trop-2 such as sacituzumab-govitecan and datopotomab-deruxtecan have garnered tremendous interest fo...
aacrjournals.org
January 23, 2025 at 10:30 PM